Back to top

Merck & Co Inc: (MRK)

(Market Close from NYSE)

 Add to portfolio

 ZacksTrade Now

$57.75 USD

57.75
8,457,826

+0.15 (0.26%)

Updated Mar 27, 2015 04:00 PM ET

Volume: 8,457,826

Open: $57.83

Prior Close: $57.60

Zacks Rank : 3-Hold [?]     3    

Style Scores [?] : Growth: F | Value: B | Momentum: F

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.

We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:

Zacks Style Score A
Growth Score A
Value Score A
Momentum Score A
Income Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.

Zacks Scorecard Education - Learn more about the Zacks Scorecard

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The three scores are based on the trading styles of Growth, Value, and Momentum.

Growth Score A
Value Score A
Momentum Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Company Summary

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.

General Information

MERCK & CO INC

2000 GALLOPING HILL ROAD

KENILWORTH, NJ 07033

Phone: 908-740-4000

Fax: 908-735-1253

Web: http://www.merck.com

Email: NA

Industry LARGE CAP PHARMA
Sector Medical
Fiscal Year End December
Last Reported Quarter 12/31/2014
Next EPS Date 4/28/2015

EPS Information

Current Quarter EPS Consensus Estimate 0.77
Current Year EPS Consensus Estimate 3.40
Estimated Long-Term EPS Growth Rate 7.10
Next EPS Report Date 4/28/2015

Price and Volume Information

Zacks Rank
Yesterday's Close 57.60
52 Week High 63.62
52 Week Low 52.49
Beta 0.33
20 Day Moving Average 12,166,935.00
Target Price Consensus 64.65

MRK

% Price Change
4 Week -2.31
12 Week 1.43
YTD 2.59
% Price Change Relative to S&P 500
4 Week 0.29
12 Week 1.56
YTD 0.74
Share Information
Shares Outstanding (millions) 2,838.19
Market Capitalization (millions) 163,479.92
Short Ratio 2.39
Last Split Date 2/17/1999
Dividend Information
Dividend Yield 3.13%
Annual Dividend $1.80
Payout Ratio 0.51
Change in Payout Ratio 0.05
Last Dividend Payout / Amount 3/12/2015 / $0.45

Fundamental Ratios

P/E
P/E (F1) 16.94
Trailing 12 Months 16.46
PEG Ratio 2.38
EPS Growth
vs. Previous Year -1.14%
vs. Previous Quarter -3.33%
   
Sales Growth
vs. Previous Year -7.39%
vs. Previous Quarter -0.71%
   
Price Ratios
Price/Book 3.37
Price/Cash Flow 9.71
Price / Sales 3.87
ROE
12/31/14 20.93
9/30/14 20.75
6/30/14 20.49
ROA
12/31/14 10.05
9/30/14 9.97
6/30/14 9.96
Current Ratio
12/31/14 1.77
9/30/14 1.34
6/30/14 1.87
Quick Ratio
12/31/14 1.47
9/30/14 1.11
6/30/14 1.53
Operating Margin
12/31/14 24.18
9/30/14 23.94
6/30/14 23.93
Net Margin
12/31/14 28.22
9/30/14 12.50
6/30/14 12.89
Pre-Tax Margin
12/31/14 40.92
9/30/14 15.55
6/30/14 15.46
Book Value
12/31/14 17.11
9/30/14 15.73
6/30/14 16.60
Inventory Turnover
12/31/14 2.81
9/30/14 2.87
6/30/14 2.75
Debt-to-Equity
12/31/14 0.38
9/30/14 0.41
6/30/14 0.38
Debt to Capital
12/31/14 27.71
9/30/14 29.04
6/30/14 27.70